Koyfin Home > Directory > Health Care > Akebia Therapeutics > Return on Capital %

Akebia Therapeutics Return on Capital % Chart (AKBA)

Akebia Therapeutics annual/quarterly Return on Capital % from 2013 to 2020.
  • Akebia Therapeutics Return on Capital % for the quarter ending June 06, 2020 was -14.53 a -14.12% increase of 2.05 year over year
  • Akebia Therapeutics Return on Capital % for the last 12 months ending June 06, 2020 was -22.56 a -68.77% increase of 15.52 year over year
  • Akebia Therapeutics Annual Return on Capital % for 2019 was -22.61 a -7.42% increase of 1.68 from 2018
  • Akebia Therapeutics Annual Return on Capital % for 2018 was -24.29 a -106.94% increase of 25.97 from 2017
  • Akebia Therapeutics Annual Return on Capital % for 2017 was -50.26 a -70.44% increase of 35.41 from 2016
Other Margins & Efficiency Metrics:
  • Akebia Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-142m a 62.80% decrease of -89m year over year
  • Akebia Therapeutics Return on Equity % for the quarter ending December 12, 2018 was -247.98 a 76.13% decrease of -188.78 year over year
View Chart On Koyfin

Quarterly AKBA Return on Capital % Data

06/2020-14.53
03/2020-23.81
12/2019-37.29
09/2019-16.58
06/2019-16.96
03/2019-24.49
12/2018-39.25
09/2018-45.13
06/2018-49.12
03/2018-38.32

Annual AKBA Return on Capital % Data

2019-22.61
2018-24.29
2017-50.26
2016-85.67
2015-32.71
2014-35.17
2013-61.79
2012-155.10